| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $-0.66 (Beat by $0.08) |
| EPS GAAP Actual | $-0.66 (Beat by $0.08) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.80667 |
| EPS GAAP Estimate | $-0.80667 |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | -2.93 | -16.05 | -2.93 | -2.93 | 1 |
| Dec 2028 | -3.04 | -15.47 | -3.04 | -3.04 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.66 | -0.02333 | 0B | -INF% | 0M |
| FQ1 2024 (Mar 2024) | -0.93 | -0.93 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 0.165B | 100% | 165M |
| FQ2 2025 (Jun 2025) | -0.77 | -0.24667 | 0B | -INF% | -6.25M |
| FQ1 2025 (Mar 2025) | -1.15 | -0.43667 | 0B | NAN% | 0M |
| FQ3 2023 (Sep 2023) | 0 | 0 | 0B | NAN% | 0M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 0.0025B | 100% | 2.5M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.80667
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.7651 | -- | -0.7651 | -0.7651 | 1 |
| FQ3 2027 (Sep 2027) | -0.7301 | -- | -0.7301 | -0.7301 | 1 |
| FQ2 2027 (Jun 2027) | -0.7028 | -- | -0.7028 | -0.7028 | 1 |
| FQ1 2027 (Mar 2027) | -0.8011 | -- | -0.8011 | -0.8011 | 1 |
| FQ4 2026 (Dec 2026) | -0.82667 | -- | -0.82667 | -0.82667 | 1 |
| FQ3 2026 (Sep 2026) | -0.57 | -15.79 | -0.57 | -0.57 | 1 |
| FQ2 2026 (Jun 2026) | -0.57 | -35.09 | -0.57 | -0.57 | 1 |
| FQ1 2026 (Mar 2026) | -0.80667 | -42.56 | -0.80667 | -0.80667 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0B | -- | 0B | 0B | 0 |
| FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 0 |
| FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 0 |
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 0 |
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 0 |
| FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 0 |
| FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 0 |
| FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
4
EPS # of in-lines
4
Revenue # of Beats
2
Revenue # of Misses
1
Revenue # of in-lines
5
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.63667 | -0.66 | -0.02333 | 3.53% |
| FQ1 2024 (Mar 2024) | -0.93 | -0.93 | 100% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ2 2025 (Jun 2025) | -0.52333 | -0.77 | -0.24667 | 32.04% |
| FQ1 2025 (Mar 2025) | -0.71333 | -1.15 | -0.43667 | 37.97% |
| FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0.17B | $165M | 100% |
| FQ2 2025 (Jun 2025) | $0.01B | $0B | $-6.25M | -INF% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ3 2023 (Sep 2023) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $2.5M | 100% |